Corbus Pharmaceuticals (NASDAQ:CRBP) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Corbus Pharmaceuticals Trading Up 6.5 % NASDAQ:CRBP opened at $6.16 on Monday. The company has a market capitalization of $27.25 million, a P/E […]

Related Keywords

,News Ratings For Corbus Pharmaceuticals Daily ,Vident Investment Advisory ,Nasdaq ,Corbus Pharmaceuticals ,Corbus Pharmaceuticals Trading ,Sio Capital Management ,Corbus Pharmaceuticals Holdings Inc ,Dimensional Fund Advisors ,Blackrock Inc ,Institutional Investors Weigh In On Corbus Pharmaceuticals ,Free Report ,Get Free Report ,Fund Advisors ,Street Corp ,Investment Advisory ,Pharmaceuticals Holdings ,Corbus Pharmaceuticals Daily ,Nasdaq Crbp ,Crbp ,Medical ,Initiated Coverage ,Stocknews Com ,